Patents by Inventor Tina Gjoni

Tina Gjoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230255949
    Abstract: The present disclosure relates to compositions including benzimidazole derivatives. Specifically, the disclosure is generally directed to storage stable formulations of benzimidazole derivatives.
    Type: Application
    Filed: February 8, 2023
    Publication date: August 17, 2023
    Inventors: Katarina Alilovic, Tina Gjoni, Anita Bevetek Mocnik
  • Publication number: 20220218784
    Abstract: The present disclosure is related to providing a stable daptomycin aqueous pharmaceutical formulations as a contrast to the inconvenient and potentially problematic methods of lyophilized drug preparation and administration, wherein the aqueous formulations of daptomycin offer the advantage of ease of handling with a high degree of patient acceptability and compliance.
    Type: Application
    Filed: May 8, 2020
    Publication date: July 14, 2022
    Inventors: Tina Gjoni, Dubravka Strazic-Novakovic, Ivona Jasprica, Stipica Tomic
  • Patent number: 10933019
    Abstract: The present invention relates to liquid pharmaceutical compositions comprising daptomycin, methods of providing such compositions and the use thereof. Provided herein are formulations comprising daptomycin, one or more polar protic solvents, and mixtures thereof. Formulations according to the present invention can further comprise polar aprotic solvent and/or source of calcium.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: March 2, 2021
    Assignee: XELLIA PHARMACEUTICALS APS
    Inventors: Tina Gjoni, Dubravka Strazic
  • Publication number: 20190240155
    Abstract: The present invention relates to liquid pharmaceutical compositions comprising daptomycin, methods of providing such compositions and the use thereof. Provided herein are formulations comprising daptomycin, one or more polar protic solvents, and mixtures thereof. Formulations according to the present invention can further comprise polar aprotic solvent and/or source of calcium.
    Type: Application
    Filed: October 17, 2017
    Publication date: August 8, 2019
    Inventors: Tina GJONI, Dubravka STRAZIC
  • Publication number: 20130035256
    Abstract: The present invention provides a method of high-throughput screening (HTS) of active agents of a cell-surface G-Protein coupled receptor (GPCR) or another target receptor of interest. The method uses a non-invasive, sensitive reporting system that is proximal to the target of interest, combined with a dynamic, automated screening procedure so as to detect orthosteric ligands, such as agonists and antagonists, but is also suitable to detect allosteric or low affinity active agents of a GPCR and possibly other disease-related receptors.
    Type: Application
    Filed: April 20, 2011
    Publication date: February 7, 2013
    Applicant: ADDEX PHARMA SA
    Inventors: Tina Gjoni, Dominik Schelshorn, Cornelia Hampe, Aurelie Gouiller, Robert Lutjens